Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
about
CD2 promotes human natural killer cell membrane nanotube formationA randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adultsAutocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responsesReduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults.Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIVAnalog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.Impact of physical activity on pain perception in an animal model of endometriosis.Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins.Regulation of NK92-MI cell cytotoxicity by substance P.Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adults.Truncation of neurokinin-1 receptor-Negative regulation of substance P signaling.Detection of the full-length transcript variant for neurokinin-1 receptor in human whole blood associated with enhanced reinforcement of clot by substance-P.
P2860
Q21133931-1465ECF0-04AF-4327-A857-ACF6B64E31C9Q28740565-3626D497-2DF0-4100-8F73-EB0AEB61BB63Q35185399-0CADFC9D-47FC-4D37-B9F6-C6B061CEA8B9Q35755634-BF104E69-C20E-407C-9657-3BE62F33E0F9Q36937565-69DF328D-62B3-4EAF-AE3A-8692A5D4C064Q37340453-00AD0081-03B1-42AF-B4E1-8A51B538FDBAQ37643571-54F87124-6235-4212-81A7-86630E06E270Q38625810-569E44ED-52B7-4542-9640-2699F76FD525Q39581294-02D3F8F2-3E4F-4F1B-93ED-9434DD7C2348Q40085168-7837E750-1F79-44C1-9B6E-7991DEE44316Q41924104-BCB5248B-9131-4256-877B-6B10521C37F3Q49972918-F2EAF9FA-88FB-4165-8469-A8DBFD89ABD6Q54340638-CE876C43-3C03-46A1-8DCA-FC44843704DF
P2860
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
@ast
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
@en
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
@nl
type
label
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
@ast
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
@en
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
@nl
prefLabel
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
@ast
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
@en
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
@nl
P2093
P2860
P356
P1476
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
@en
P2093
Chang-Jiang Guo
Florin Tuluc
Jian Ping Lai
Laurie E Kilpatrick
Linda Monaco-Shawver
Lynnae Schwartz
Pinaki P Banerjee
Satya M Gunnam
Steven D Douglas
P2860
P304
P356
10.1189/JLB.0410200
P577
2010-10-12T00:00:00Z